Lv1
30 积分 2024-04-23 加入
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
6小时前
待确认
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
1个月前
已完结
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
4个月前
已完结
Multiancestry genomic and transcriptomic analysis of gastric cancer
5个月前
已完结
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
5个月前
已完结
Interstitial lung diseases
6个月前
已完结
[Chinese expert consensus on multidisciplinary discussion of interstitial lung disease]
6个月前
已完结
Pharmacodynamic Modeling of CDK4/6 Inhibition‐Related Biomarkers and the Characterization of the Relationship Between Biomarker Response and Progression‐Free Survival in Patients With Advanced Breast Cancer
8个月前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
9个月前
已完结
Targeting DNA damage response pathways in cancer
9个月前
已完结
皖公网安备34019202002308
